Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays
K Uhteg, J Jarrett, M Richards, C Howard… - Journal of Clinical …, 2020 - Elsevier
In December 2019, a novel coronavirus (SARS-CoV-2) was first isolated from Wuhan city,
China and within three months, the global community was challenged with a devastating
pandemic. The rapid spread of the virus challenged diagnostic laboratories to rapidly
develop molecular diagnostic methods. As SARS CoV-2 assays became available for
testing on existing molecular platforms, laboratories devoted unprecedented energy and
resources into evaluating the analytical performance of the new tests and in some cases …
China and within three months, the global community was challenged with a devastating
pandemic. The rapid spread of the virus challenged diagnostic laboratories to rapidly
develop molecular diagnostic methods. As SARS CoV-2 assays became available for
testing on existing molecular platforms, laboratories devoted unprecedented energy and
resources into evaluating the analytical performance of the new tests and in some cases …